Figure 2
Disease-free survival in the full analysis set (A) and patient subgroups with HER2-negative (B), HER2-positive (C), or triple-negative (D) disease.
Figure 2 | British Journal of Cancer
Disease-free survival in the full analysis set (A) and patient subgroups with HER2-negative (B), HER2-positive (C), or triple-negative (D) disease.
